The global clinical trial landscape of PD-1-containing bispecific antibodies for gastric cancer: current status and future directions of targeting immune tolerance - Quiz - MDSpire

The global clinical trial landscape of PD-1-containing bispecific antibodies for gastric cancer: current status and future directions of targeting immune tolerance

  • By

  • Ziyue Sha

  • Zhengzheng Ji

  • Lanqing Zhao

  • Song Wang

  • Zhanjun Guo

  • June 22, 2026

  • 0 min

Share

Original Source(s)

The global clinical trial landscape of PD-1-containing bispecific antibodies for gastric cancer: current status and future directions of targeting immune tolerance

  • by Ziyue Sha, Zhengzheng Ji, Lanqing Zhao, Song Wang, Zhanjun Guo

  • June 22, 2026

Related Content

Endovascular thrombectomy in selected patients with active cancer and thrombocytopenia: outcomes under an institutional platelet transfusion practice

Radiomics-based interpretable machine learning model from multiphasic CT imaging for predicting pathological grade in upper tract urothelial carcinoma: a multicenter study

Immune heterogeneity and therapeutic resistance in gynecological malignancies